SEARCH

SEARCH BY CITATION

References

  • 1
    Apperley, J.F., Jones, L., Hale, G., Goldman, J.M., Galton, D.G. (1986) Bone marrow transplantation for chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of acute graft-versus-host disease but may increase the risk of leukemic relapse. Bone Marrow Transplantation, 1, 53 66.
  • 2
    Aversa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Iacucci, R., Zei, T., Martelli, M.P., Gambelunghe, C. (1994) Successful engraftment of T-cell-depleted haploidentical ‘three-loci’ incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood, 84, 3948 3955.
  • 3
    Bacigalupo, A., Zikos, P., Van Lint, M.T., Valbonesi, M., Lamparelli, T., Gualandi, F., Occhini, D., Mordini, N., Bregante, S., Berisso, G., Vitale, V., Sessarego, M., Marmont, A.M. (1998) Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience. Experimental Hematology, 26, 409 414.
  • 4
    Barrett, A.J., Mavroudis, D., Tisdale, J., Molldrem, J., Clave, E., Dunbar, C., Cottler-Fox, M., Phang, S., Carter, C., Okunnieff, P., Young, N.S., Read, E.J. (1998) T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplantation, 21, 543 551.
  • 5
    Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chouncey, T., Storb, B., Buckner, C.D. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825 831.
  • 6
    Bensinger, W., Appelbaum, F., Rowley, S., Storb, B., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Reginald, C., Chouncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R.P., Buckner, C. (1995) Factors that influence collection and engraftment of autologous peripheral blood stem cells. Journal of Clinical Oncology, 13, 2547 2555.
  • 7
    Bensinger, W.I., Clift, R., Martin, P., Appelbaum, F.R., Demirer, T., Gooley, T., Lilleby, K., Rowley, S., Sanders, J., Storb, R., Buckner, C.D. (1996) Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 88, 2794 3800.
  • 8
    Butturini, A. & Gale, R.P. (1988) T-cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplantation, 3, 185 192.
  • 9
    Cottler-Fox, M., Cipolone, K., Yu, M., Berenson, R., O'shaughnessy, J., Dunbar, C. (1995) Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Experimental Hematology, 23, 320 322.
  • 10
    Couriel, D., Canosa, J., Engler, H., Collins, A., Dunbar, C., Barrett, J. (1996) Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplantation, 18, 347 353.
  • 11
    Hartung, G., Uharek, L., Zeis, M., Glass, B., Steinmann, J., Dreger, P., Kronke, M., Schimitz, N. (1998) Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone. Bone Marrow Transplantation, 21, S16 S20.
  • 12
    Johnson, B.D., Drobyski, W.R., Truitt, R.L. (1993) Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplantation, 11, 329 336.
  • 13
    Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
  • 14
    Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., Van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S., Bortin, M. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120 2130.
  • 15
    Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C., Barrett, J. (1996) CD34+ cell dose predicts survival, posttransplant morbidity and rate of hematological recovery after allogeneic marrow transplants for hematologic malignancies. Blood, 88, 3223 3229.
  • 16
    Noga, S.J., Seber, A., Davis, J.M., Berenson, R.J., Vogelsang, G.B., Braine, H.G., Hess, A.D., Marcellus, D., Miller, C.A., Sharkis, S.J., Goodman, S.N., Santos, G.W., Jones, R.J. (1998) CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment. Journal of Hematotherapy, 7, 151 157.
  • 17
    Peto, R. & Peto, J. (1972) Asymptotically efficient rank invariant procedures. Journal of the Royal Statistical Society, 135, 185 194.
  • 18
    Prentice, H.G., Gluckman, E., Powles, R., Ljungman, P., Milpied, N.J., Fernandez-Ran~ada, J.M., Mandelli, F., Kho, P., Kennedy, L., Bell, A.R. for the European Acyclovir for CMV Prophylaxis Study Group. (1994) Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet, 343, 749 753.
  • 19
    Reisner, Y. & Martelli, M.F. (1995) Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunology Today, 16, 437 440.
  • 20
    Ringden, O. & Ringden, O. (1985) Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation, 40, 39 44.
  • 21
    Roscoe, R.A., Rybka, W., Winkelstein, A., Housto, A.M., Kiss, J.E. (1994) Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry, 16, 74 79.
  • 22
    Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M., Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 4226 4235.
  • 23
    Weaver, C., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L., West, W. (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood, 86, 3961 3969.